According to the Human Protein Atlas, higher levels of TAL/LRSAM1 may serve as favorable prognostic markers in pancreatic and renal cancers, but it remains to be determined whether variations in the expression of TAL/LRSAM1 in selected cancer subtypes also correlate with changes in TSG101 protein levels. The gene discussed is LRSAM1; the disease is cancer.